Peginesatide is noninferior to epoetin for anemia in hemodialysis patients [EMERALD Trials]
1. Hemodialysis patients who received peginesatide had similar hemoglobin levels and similar rates of adverse events as patients who received ...
1. Hemodialysis patients who received peginesatide had similar hemoglobin levels and similar rates of adverse events as patients who received ...
Monthly plan selected: $4.99 /month.
5-day free trial · cancel anytime
Then $4.99/month. Manage renewal in your account.
Yearly plan selected: $49.90 /year.
2 months free · only $4.16/month
Then $49.90/year. Manage renewal in your account.
Already a member? Sign in
